Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Whitehall-Robins, Novartis, Retailers Named In PPA Personal Injury Lawsuits

This article was originally published in The Tan Sheet

Executive Summary

Retailers are named alongside drug companies as defendants in two new personal injury lawsuits related to phenylpropanolamine-containing OTC cough/cold products.

You may also be interested in...



E'Ola Appealing $13.3 Mil. Ephedrine Supplement Verdict

A $13.3 mil. jury verdict for an Alaska woman who claimed her stroke was caused by ephedrine alkaloid-containing dietary supplements could open the door to new lawsuits against the industry.

Retailer In-Store Signs Explain PPA Product Removal To Customers

Drugstore chains including Walgreens, Rite Aid, Kroger's and CVS are developing signs to explain to consumers why phenylpropanolamine-containing products have been voluntarily removed from store shelves.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS092214

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel